Tci Wealth Advisors, Inc. Exelixis, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$16.3 - $19.41 $2,950 - $3,513	181 Added 32.67%	735 $14,000
Q4 2022 Feb 06, 2023	SELL	$14.96 - $17.39 $4,338 - $5,043	-290 Reduced 34.36%	554 $8,000
Q3 2022 Nov 08, 2022	BUY	$15.68 - $22.27 $13,233 - $18,795	844 New	844 $13,000
Q1 2020 Apr 14, 2020	SELL	$14.46 - $21.8 $1,446 - $2,180	-100 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$17.68 - $22.65 $1,768 - $2,265	-100 Reduced 50.0%	100 $2,000
Q3 2018 Nov 02, 2018	BUY	$15.87 - $22.4 $1,587 - $2,240	100 Added 100.0%	200 $4,000
Q2 2018 Jul 27, 2018	BUY	$18.56 - $22.45 $1,855 - $2,245	100 New	100 $2,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.